Skip to main content
Eleftherios Mamounas, MD, General Surgery, Orlando, FL

EleftheriosPMamounasMD

General Surgery • Orlando, FL

Breast, Surgical Oncology (Other than Breast)

Professor of Surgery, Northeast Ohio Medical University

Join to view full profile

Dr. Mamounas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mamounas' full profile

Already have an account?

  • Office

    2501 N Orange Ave
    Ste 389
    Orlando, FL 32804
    Phone+1 407-303-5214
    Fax+1 407-909-6944

Education & Training

  • UPMC Medical Education (Pittsburgh)
    UPMC Medical Education (Pittsburgh)Residency, Surgery, 1984 - 1989
  • University of Athens
    University of AthensClass of 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2012 - 2025
  • OH State Medical License
    OH State Medical License 1997 - 2014
  • PA State Medical License
    PA State Medical License 1985 - 1998
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • 21-Gene Assay as Predictor of Chemotherapy Benefit in HER2-Negative Breast Cancer  
    Eleftherios P Mamounas, Frederick L Baehner, Norman Wolmark, D Lawrence Wickerham, Nature
  • Clinical Relevance of the 21-Gene Recurrence Score® Assay in Treatment Decisions for Patients with Node-Positive Breast Cancer in the Genomic Era  
    Eleftherios Mamounas, MD, Nature

Lectures

  • NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ... 
    2019 ASCO Annual Meeting - 6/1/2019
  • NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • 21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy plus Endocrine Therapy: Results from NSABP B-28/NRG Oncology
    21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy plus Endocrine Therapy: Results from NSABP B-28/NRG OncologyNovember 11th, 2019
  • Do Trials Results Conflict for Extended AI in Breast Cancer?
    Do Trials Results Conflict for Extended AI in Breast Cancer?December 8th, 2016
  • Conversations with Oncology Investigators Bridging the Gap Between Research and Patient Care
    Conversations with Oncology Investigators Bridging the Gap Between Research and Patient CareDecember 26th, 2007
  • Join now to see all

Professional Memberships

Dr. Eleftherios Mamounas, Dr. Eleftherios Mamounas, MD, Dr. E Mamounas, Dr. Eleftherios P Mamounas